Nest Collective Foundation
VC Fund
Nest Collective Foundation is a VC fund focused on Health Care and Medical Device. The first ecological and ethical pension fund in Switzerland.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Nest Collective Foundation invests in
Stages Nest Collective Foundation invests in
Countries Nest Collective Foundation invests in
Investment Focus
Industry
- Health Care 3 (75%)
- Medical Device 3 (75%)
- Medical 1 (25%)
- Neuroscience 1 (25%)
- Therapeutics 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ARTIRIA Medical
|
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases. | $6M / Series A / Feb 27, 2024 | |
Piomic
|
There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg andfoot ulcers.The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life. The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.By developing a therapy which is safe and effective we hope to set a better future for patients in need. | $7.9M / Series A / Jul 29, 2022 | |
|
ARTIRIA Medical
|
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases. | $3.2M / Series A / Jul 15, 2020 | |
DBS System
|
DBS System SA, producer of HemaXis™ blood collection devices, is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes.They produce devices with patented microfluidic technology capableof plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis.DBS System is “Unleashing Labs to Stay Well”. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well.HemaXis will help democratize blood collection and support “big data” initiatives important to the development of effective and efficient personalized medicine. | $2.9M / Series A / May 04, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nest Collective Foundation invest in?
Nest Collective Foundation invests primarily in Health Care, Medical Device and Medical startups, most often at Series A stage. Most of the 4 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nest Collective Foundation last invest?
The most recent investment recorded for Nest Collective Foundation closed in Feb 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
